Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
CHICAGO (Reuters) - In the latest installment in the mammogram debate, a new study finds that getting a mammogram every other year instead of annually did not increase the risk of advanced breast cancer in women aged 50 to 74, even in women who use hormone therapy or have dense breasts, factors that increase a woman's cancer risk.
Qigong may help ease symptoms of depression in women undergoing radiation treatment for breast cancer and also lessen fatigue in those who reported symptoms of depression before beginning treatment, a study shows.
A recent study found that African-American women with breast cancer reported more fatigue, worse hot flashes and worse sleep quality than African-American women without cancer. Yet overall, both groups of women reported nearly the same level of social support, emotional distress and life satisfaction.
NEW YORK (Reuters) - Women who have ever had breast cancer might want to walk away from the brie, the butter and the black cherry (and every other flavor) ice cream.
NEW YORK (Reuters Health) - The radiation that might cure a breast cancer may also raise a woman's risk of having a heart attack or heart disease later in life, according a new study that looked back at the cases of 2,168 women in Sweden and Denmark.
Talking about end-of-life wishes soon after a metastatic cancer diagnosis may lead to less aggressive, and potentially more comfortable, treatment in the last month of life, a recent analysis showed.
Women with HER2 positive metastatic breast cancer whose cancer grows despite other standard therapies have a new treatment option available next month, now that the Food and Drug Administration approved the EMILIA study’s T-DM1.
NEW YORK (Reuters Health) - More young women are being diagnosed with advanced, metastatic breast cancer than were three decades ago, a new study suggests - although the overall rate of cancers in that group is still small.
A retrospective analysis of 4,554 women treated with taxane-based chemotherapy found that though neuropathy is a common side effect, its presence does not predict better outcomes such as longer overall survival or lower risk of recurrence. Neuropathy is damage to the nervous system that causes pain, numbness, tingling or swelling of the hands or feet.
(Reuters) - U.S. health regulators approved a new drug made by Roche Holding AG for some patients with late-stage metastatic breast cancer who fail to respond to other therapies.